New Search

If you are not happy with the results below please do another search

Generic filters

50 search results for:


Accord BioPharma and EVERSANA Announce Partnership to Support the Launch of CAMCEVI for the Treatment of Advanced Prostate Cancer in Adults in the U.S.

CAMCEVI is the first-ever ready-to-inject sterile formulation of leuprolide for subcutaneous injection that comes in a pre-filled syringe with no mixing required. Accord BioPharma, the U.S. specialty division of Intas Pharmaceuticals, Ltd., is heading distribution in the United States.